Topic Listing for Cutera

Ability Compete Effectively Depends Innovate Develop Acquire Commercialize Accessories Replacement Handpieces
Accounting Impact Accounting Income Taxes
Accounting Stock-based Compensation Accounts Receivable
Accrued Liabilities Accrued Rights Surviving Obligations
Acquisitions Make Disrupt Business Harm Financial Condition Adequacy Cash Resources Meet Future Needs
Adjustments Non-employee Director Compensation Adversely Affected
Advertising Costs Aesthetic Equipment Market Characterized Rapid Innovation Compete Effectively
Aesthetic Procedures Improving Skins Appearance Limitations Allowance Doubtful Accounts
Allowance Inventory Amendment
Amendment 2003 Development License Agreement Between Gillette Palomar Amendment 2004 Equity Incentive Plan
Amendment Sales Agent Agreement Amortization Deferred Stock-based Compensation
Amortization Stock-based Compensation Annual Meeting Stockholders
Anti-dilutive Securities Anti-takeover Provisions Amended Restated Certificate Incorporation Bylaws Delaware
Applications Procedures Audit Non-audit Services
Availability Cancelled Options Future Awards Available Information
Background Basis Presentation
Because Not Require Training Users Products North America Because Not Require Training Users Products Sell Non-physicians
Because Not Require Training Users Products Sell Times Beneficial Ownership Reporting Compliance
Benefit Income Taxes Benefit Provision Income Taxes
Benefits Option Exchange Program Eligible Participants Board Directors Recommends Stockholders Vote Proposals Agenda
Board Directors Recommends Vote Following Proposals Brochures Cutera Current Products
Calendar Shall Mean Each Period Consecutive Ending Cash Equivalents Investments
Cash Equivalents Marketable Investments Cash Equivalents Marketable Investments Long Term
Cash Equivalents Marketable Investments Long Term Summary Cash Equivalents Marketable Investments Long-term
Cash Equivalents Marketable Investments Summary Cash Equivalents Marketable Securities
Cash Flows Cash Flows Financing Activities
Cash Flows Investing Activities Cash Flows Operating Activities
Cash Provided Financing Activities Cash Provided Operations
Cash Provided Used Investing Activities Cash Used Investing Activities
Caution Regarding Forward-looking Statements Certain Relationships Related Transactions
Change Compensation Directors Change Compensation Executive Officers
Change Compensation Named Executive Officers Change Composition Compensation Committee
Changes 2004 Plan Changes Internal Control Over Financial Reporting
Changes Securities Proceeds Chief Financial Officer
Classes Board Directors Clearance Food Drug Administration Market Titan Product Only
Clearance Pathway Clinical Trials
Code Ethics Commitments
Committee Committees Board
Common Stock Common Stock Repurchase Program
Common Stockholders Communications Board Stockholders
Compared Same 2004 Compared Same 2005
Compared Same 2006 Comparison Cumulative Total Return
Compensation Compensation Chief Executive Officer
Compensation Committee Charter Compensation Committee Interlocks Insider Participation
Compensation Committee Members Compensation Committee Report
Compensation Components Compensation Philosophy
Compensation Program Compete Against Companies Longer Operating Histories Established Products
Compete Against Companies Longer Operating Histories Newer Different Competition
Competition Among Providers Laser Other Energy-based Devices Aesthetic Competition Among Providers Laser Other Light-based Devices Aesthetic
Compliance Filing Requirements Components Used Products Complex Design Defects Not Discovered
Comprehensive Income Comprehensive Income Loss
Comprehensive Loss Concentration Credit Risk Other Risks Uncertainties
Conference Call Conference Call Scheduled Today 830 Edt
Confidential Information Confidentiality Obligations
Consent Independent Registered Public Accounting Firm Consent Judgment
Consent Judgments Consequences Termination Agreement Palomar
Consequences Termination Exclusivity Period Event Gillette Terminates Pursuant Consolidated Financial Statements Statement Schedule
Contingencies Contractual Cash Obligations
Contractual Obligations Control Console
Controls Procedures Core Palomar Patents
Cost Revenue Costs
Critical Accounting Policies Estimates Cut Supply
Cutera Affiliates Cutera Announces Adjournment Annual Meeting Stockholders
Cutera Announces Stock Repurchase Program Cutera Applications Procedures
Cutera Covenanting Affiliates Cutera Hair Products
Cutera Inc Cutera Inc 2008 Annual Meeting Stockholders Held
Cutera Inc 2009 Annual Meeting Stockholders Held Cutera Reports 2006 Results
Cutera Reports 2007 Results Cutera Reports 2008 Results
Cutera Reports 2009 Results Cutera Reports Full 2006 Results
Cutera Reports Full 2007 Results Cutera Reports Full-year 2008 Results
Cutera Reports Preliminary 2007 Revenue Eps Cutera Reports Strong 2005 Results Raises Guidance
Cutera Settles Patent Litigation Palomar Cuteras Product Warranty
Defects Design Material Workmanship Products Not Discovered Prior Deferred Service Contract Revenue
Defined Contribution Plan Definition Disclosure Controls
Definitions Delegation Authority
Departure Directors Principal Officers Election Appointment Depend Skilled Experienced Personnel Operate Business Effectively Unable
Description Description Operations
Description Operations Principles Consolidation Details Option Exchange Program
Development License Agreement Difficult Predict Future Performance Success Dependent Number Factors
Director Compensation Director Independence
Director Nomination Process Director Nominees
Directors Whose Terms Extend Beyond 2005 Annual Meeting Directors Whose Terms Extend Beyond 2006 Annual Meeting
Directors Whose Terms Extend Beyond 2007 Annual Meeting Directors Whose Terms Extend Beyond 2008 Annual Meeting
Directors Whose Terms Extend Beyond 2009 Annual Meeting Disclosure Controls Procedures
Disclosure Schedule District Delaware
Dividend Policy Documents Incorporated Reference
Duties Compensation Committee Economic Adjustments Off-label Sales
Effective 2003 Effective Income Tax Rate Vary Significantly
Election Participate Eligibility
Employee Benefit Plan Employee Stock Purchase Plan
Employees Employment Agreements
Entering Difficult Economic Period Uncertainty Economy Increase Stock Entry Material Definitive Agreement
Equity Compensation Plan Information Equity Incentive Plan 1998 Stock
Estimates Evaluation Disclosure Controls Procedures
Exact Name Registrant Specified Charter Example
Exchange Ratio Executive Officers Senior Management
Executive Summary Exercise Price New Options
Exhibits Expense Potential Unavailability Insurance Coverage Customers Adversely Affect
Explanatory Exposed Fluctuations Market Values Portfolio Investments Interest Rates
Exposure Additional Tax Liabilities Negatively Impact Income Provision Facility Lease
Facility Leases Factors Impact Future Performance
Fail Comply Fdas Quality System Regulation Laser Performance Fail Obtain Clearance Food Drug Administration Market Titan
Fail Obtain Maintain Necessary Fda Clearances Products Indications Fail Obtain Maintain Necessary Food Drug Administration Clearances
Failure Maintain Effective Internal Control Over Financial Reporting Failure Maintain Effective Internal Controls Over Financial Reporting
Fair Value Financial Instruments Fair Value Measurements
Family Relationships Fdas Pre-market Clearance Approval Requirements
Federal Income Tax Consequences Federal Tax Aspects
Ffdca Shall Mean United States Federal Food Drug Fin Income Tax Liability
Financial Results Affected Accounting Rules Governing Recognition Stock-based Financial Results Affected Changed Accounting Rules Governing Recognition
Financial Statements Financial Statements Exhibits
Fold Detach Here Forecast Sales Determine Requirements Components Materials Used Products
Foreign Currency Foreign Currency Exchange Risk
Form 10-q Formation Business
Former Name Address Changed Since Last Report Forward Looking Statements
Full 2005 Compared 2004 Full-year 2006 Compared 2005
General General Administrative
Gillette Agreement Gillette Rights Obligations Period
Gillettes Commercialization Rights Obligations Gillettes Decision Point
Government Regulation Grant
Grants Gillette Grants Palomar
Grants Plan-based Awards Gross Margin
Gross Operating Margins Vary Over Time Gross Profit
Guidance Half 2006
Half 2007 Hand Pieces
Handpiece Titan Field Upgrade Pricing Handpieces
Held 2005 Held 2006
Held 2007 Held 2008
Held 2009 Impact Adoption Fin
Impact Adoption Sfas 123 Impairment Long-lived Assets
Implementing Stock Option Exchange Program Income Tax
Income Tax Liability Income Taxes
Incur Substantial Expenses Practices Shown Violated Telephone Consumer Indemnification Procedure
Indemnifications Indemnity
Index Index Consolidated Financial Statements
Index Exhibits Infringement Party Rights
Initial Public Offering Initiatives Implementing Effort Improve Revenue Profitability Unsuccessful Harm
Initiatives Implementing Effort Improve Sales Productivity Revenue Income Intangible Assets
Intellectual Property Litigation Palomar Costly Prevent Selling Products Intellectual Property Ownership
Intellectual Property Rights Not Provide Adequate Protection Some Interest Other Income Expense Net
Interest Other Income Net Interest Rate Sensitivity
Interim Financial Information Internal Control Over Financial Reporting
Internal Revenue Code 162 Limitations Executive Compensation International
International Revenue Growth Cash Generated Operations Introduction
Inventories Inventory
Investor Relations Involved Costly Intellectual Property Litigation Palomar Medical Technologies
Involved Future Costly Intellectual Property Litigation Impact Business Issued Patents
Issuer Purchases Equity Securities Key Distributor Fails Perform Expectations Fail Achieve Anticipated
Key Personnel Lack Customer Demand Products Markets Harm Revenue
Lack Demand Products Markets Harm Anticipated Revenue Growth Lack Demand Products Medi-spa Market Harm Anticipated Revenue
Lack Demand Products Non-core Market Harm Anticipated Revenue Laser Lamp Products
Laser Other Light-based Aesthetic Treatments Legal Proceedings
Limitation Damages Liability Limitations Effectiveness Controls
Limited History Operations Impair Ability Grow Significantly Liquidity Capital Resources
List Cutera Combination Products Litigation
Litigation Settlement Long-lived Asset Impairment
Long-term Auction Rate Securities Investments Management Estimates
Managements Report Internal Control Over Financial Reporting Manufacturing
Manufacturing Operations Dependent Third-party Suppliers Making Vulnerable Supply Market Aesthetic Procedures
Market Benchmarks Market Non-surgical Aesthetic Procedures
Meetings Meetings Attended Directors
Membership Mgh Agt 2006a20842
Mgh Patents Minutes
Miscellaneous Modify Fda Approved Devices Need Seek Re-approval Not
Modify Fda-approved Devices Need Seek Re-approval Not Granted Name Person Filing Proxy Statement Other Registrant
Named Executive Officers Narrative Regarding Definition Cutera Combination Products
Navigation Limelight Upgrade Introductory Pricing Xeo Only Net Cash Provided Financing Activities
Net Cash Provided Operating Activities Net Cash Provided Used Financing Activities
Net Cash Provided Used Investing Activities Net Cash Provided Used Operating Activities
Net Cash Used Investing Activities Net Income Loss Per Share
Net Income Per Diluted Share Net Income Per Share
Net Loss Per Share Net Revenue
New Sales Professionals Team Unable Effectively Train Retain News Release 2006 600 Est
Nine-months 2006 Non-employees Option Grants
Non-gaap Presentation Non-gaap Pro-forma Basis Presentation
Non-surgical Aesthetic Procedures Improving Skins Appearance Limitations North American Sales Team New Professionals Managers Unable
North American Sales Team New Professionals Unable Effectively Not Paid Dividends Past Expect Pay Future Return
Not Proxy Card Wish Cast Vote Traditional Request Not Sufficient Consumer Demand Procedures Performed Products Practitioner
Not Sufficient Demand Procedures Performed Products Practitioner Inhibited Notice Withdrawal
Number Awards Granted Employees Consultants Directors Objectives Option Exchange Program
Off-balance Sheet Arrangements Offer Payment Terms Qualified Customers Event Default Affect
Option Activity Option Exchange Program
Option Grants 2004 Option Grants 2005
Option Male Field Options Exercised Stock Vested
Order Ost Revenue
Other Conditions New Options Other Contingencies
Other Current Assets Other Current Assets Prepaid Expenses
Other Events Other Information
Other Legal Matters Other Matters
Other-than-temporary Impairment Long Term Investments Other-than-temporary Impairments Long-term Investments
Overview Pacific Time
Palomar Costs Palomar Covenants Relating Exploitation Technology Products
Palomar Current Products Palomars Post-rd Period
Part Part Other Information
Patent Litigation Settlement Payment Palomar Subject Audit Result Patents Proprietary Technology
Payments Gillette Payments Palomar Gillette Joint Independent Products Other
Pending Applications Performance Graph
Periods Prior Adoption Sfas 123 Pervasive Continuing Regulation
Plan Post-warranty Service Titan Hand Piece Refills
Potential Modification Terms Comply Governmental Requirements Power Attorney
Pre-market Approval Pathway Pre-market Approval Pma Pathway
Preferred Stock Press Release Contains Forward-looking Statements Within Meaning Private
Price Common Stock Fluctuate Substantially Price Common Stock Fluctuate Substantially Limited Number Shares
Principles Consolidation Proceeds
Product Liability Suits Brought Against Due Defective Design Product Modifications
Product Pricing Product Recall
Product Upgrades Products
Profit Margins Vary Over Time Property Equipment
Property Equipment Net Proposal Four-ratification Pricewaterhousecoopers Llp Independent Registered Public Accounting
Proposal Three-approval Option Exchange Program Executive Officers Independent Proposal Three-ratification Appointment Independent Registered Public Accounting Firm
Proposal Two-approval Adoption 2004 Equity Incentive Plan Amended Proposal Two-approval Option Exchange Program Employees
Proposal Two-ratification Appointment Independent Registered Public Accounting Firm Prosecution Patents
Provision Benefit Income Tax Provision Benefit Income Taxes
Provision Income Taxes Pss World Medical Fails Perform Expectations Fail Achieve
Public Guidance Future Operating Performance Not Meet Investor Purchase Commitments
Purpose Pursuant 302 Sarbanes-oxley Act 2002
Quantitative Qualitative Disclosures Market Risk Quarterly Royalty Payments Patent License Palomar Subject Annual
Quarterly Royalty Payments Patent Sublicense Palomar Subject Annual Raises 2006 Revenue Guidance
Recent Accounting Pronouncement Recent Accounting Pronouncements
Recent Pronouncements Recitals
Records Retention Audit Redeemable Convertible Preferred Stock
Registrants Telephone Number Including Area Code Reliance Key Distributor
Rely Heavily Sales Professionals Market Sell Products Worldwide Report Audit Committee
Report Compensation Committee Report Independent Registered Public Accounting Firm
Report Management Internal Control Over Financial Reporting Reports
Research Development Research Development Expenditures
Responsibilities Restricted Cash
Restricted Stock Unit Awards Restricted Stock Unit Withholdings
Results Operations Results Operations Financial Condition
Revenue Earnings Difficult Predict Decision Not Provide Public Revenue Earnings Difficult Predict Inability Provide Public Guidance
Revenue Recognition Role Compensation Committee
Role Compensation Committee Consultant Setting Executive Role Executives Setting Compensation
Royalty Payments Owed Cutera Combination Products Rule 13a-14 Certification Chief Executive Officer
Rule 13a-14 Certification Chief Financial Officer Sales Marketing
Sarbanes-oxley Act 2002 Schedules Date Earnings Release
Securities Authorized Issuance Equity Compensation Plans Securities Exchange Act 1934
Securities Registered Pursuant Act Security Ownership Certain Beneficial Owners Management
Segment Geographic Major Customer Information Service Contract Revenue
Service Contracts Service Support
Services Compensation Services Support
Sets New Record Quarterly Revenue- Sets New Records Quarterly Revenue Eps
Sets New Records Revenue Profitability Raises Guidance- Share-based Compensation
Shipping Handling Costs Signature
Signatures Significant Accounting Policies
Significantly Exceeds Revenue Earnings Guidance- Software Upgrades
Statement Philosophy Stipulation Dismissal Prejudice
Stock Based Compensation Stock Exchange Listing
Stock Option Exercises Values 2004 Stock Option Exercises Values 2005
Stock Option Plans Stock Performance Graph
Stock Prices Stock Repurchase Program
Stock-based Compensation Stock-based Compensation Expense
Stock-based Compensation Expense Adjustments Adversely Affects Reported Financial Stock-based Compensation Expenses
Stockholders Strategy
Structure Skin Conditions Affect Appearance Subject Fluctuations Exchange Rate Dollar Foreign Currencies
Sublease Agreement Submission Matters Vote Security Holders
Subscription Agreement Subsequent Event
Success Depends Market Acceptance Products Been Recently Introduced Successfully Market Sell Products Internationally Address Issues Little
Successfully Market Sell Products Internationally Address Issues Unique Summary
System Upgrade Pricing Table Contents
Technology Design Systems Term
Term New Options Termination Agreement Either Party Material Breach
Termination Material Definitive Agreement Title Class
Total Revenue Ttp Royalty Payments
Unable Obtain Maintain International Regulatory Qualifications Approvals Current Uncertain Tax Positions
Unfavorable Results Intellectual Property Litigation Palomar Medical Technologies Unilateral Termination Agreement Gillette
Updated 2006 Guidance Valuation Assumptions
Valuation Assumptions Fair Value Stock Option Espp Grants Valuation Inventories
Various Patent Matters Vesting Commencement Date
Vesting New Options Vote Important
Vote Required Warranty
Warranty Accrual Warranty Obligations
Warranty Reserve Warranty Service Contracts
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki